Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) as induction treatment for newly diagnosed Multiple Myeloma (MM) is associated with a lower rate of Second Primary Malignancies (SPMs) compared to Thalidomide-Dexamethasone (TD)

被引：0
|
作者：
Brioli, A. [1 ,2 ]
Pezzi, A. [2 ]
Muegge, L-O [1 ]
Derudas, D. [3 ]
Petti, M. C. [4 ]
Zannetti, B. A. [2 ]
Ferrara, F. [5 ]
Rocchi, S. [2 ]
Nobile, F. [6 ]
Baraldi, A. [7 ]
Musto, P. [8 ]
Lanza, F. [9 ]
Mancuso, K. [2 ]
Canepa, L. [10 ]
Catalano, L. [5 ]
Lazzaro, A. [11 ]
Pinotti, G. [12 ]
Boccadoro, M. [13 ]
Hochhaus, A. [1 ]
Cavo, M. [2 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Hamatol & Internist Onkol, Jena, Germany
[2] Univ Bologna, Seragnoli Inst Hematol, Sch Med, Bologna, Italy
[3] GIMEMA, Italian Myeloma Network, Cagliari, Italy
[4] GIMEMA, Italian Myeloma Network, Rome, Italy
[5] GIMEMA, Italian Myeloma Network, Naples, Italy
[6] GIMEMA, Italian Myeloma Network, Reggio Di Calabria, Italy
[7] GIMEMA, Italian Myeloma Network, Alessandria, Italy
[8] GIMEMA, Italian Myeloma Network, Rionero In Vulture, Italy
[9] GIMEMA, Italian Myeloma Network, Cremona, Italy
[10] GIMEMA, Italian Myeloma Network, Genoa, Italy
[11] GIMEMA, Italian Myeloma Network, Piacenza, Italy
[12] GIMEMA, Italian Myeloma Network, Varese, Italy
[13] GIMEMA, Italian Myeloma Network, Turin, Italy
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P239
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [1] Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) and High-Dose Melphalan (HDM) As First Line Treatment for Multiple Myeloma (MM) Is Associated with a Lower Rate of Second Primary Malignancies (SPMs) Compared to TD Plus HDM
    Brioli, Annamaria
    Pezzi, Annalisa
    Derudas, Daniele
    Petti, Maria Concetta
    Zannetti, Beatrice Anna
    Ferrara, Felicetto
    Rocchi, Serena
    Nobile, Francesco
    Baraldi, Anna
    Musto, Pellegrino
    Lanza, Francesco
    Mancuso, Katia
    Canepa, Letizia
    Catalano, Lucio
    Lazzaro, Antonio
    Pinotti, Graziella
    Boccadoro, Mario
    Cavo, Michele
    [J]. BLOOD, 2014, 124 (21)
  • [2] Bortezomib (velcade(R))-thalidomide-dexamethasone (VTD) vs thalidomide-dexamethasone (TD) in preparation for autologous stem-cell (SC) transplantation (ASCT) in newly diagnosed multiple myeloma (MM)
    Cavo, Michele
    Patriarca, Francesca
    Tacchetti, Paola
    Galli, Monica
    Perrone, Giulia
    Petrucci, Maria Teresa
    Brioli, Annamaria
    Bringhen, Sara
    Pantani, Lucia
    Tosi, Patrizia
    Crippa, Claudia
    Zamagni, Elena
    Di Raimondo, Francesco
    Narni, Franco
    Cellini, Claudia
    Ceecolini, Michela
    Pescosta, Norbert
    Goldaniga, Maria Cecilia
    Montefusco, Vittorio
    Callea, Vincenzo
    De Stefano, Valerio
    Caravita, Tommaso
    Boccadoro, Mario
    Baccarani, Michele
    [J]. BLOOD, 2007, 110 (11) : 30A - 30A
  • [3] Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation.
    Garderet, Laurent
    Iacobelli, Simona
    Moreau, Philippe
    Dib, Mamoun
    Caillot, Denis
    Niederwieser, Dietger W.
    Masszi, Tamas
    Fontan, Jean
    Michallet, Mauricette
    Gratwohl, Alois
    Milone, Giuseppe
    Doyen, Chantal
    Pegourie, Brigitte
    Hajek, Roman
    Casassus, Philippe
    Kolb, Brigitte
    Chaleteix, Carine
    Hertenstein, Bernd
    Onida, Francesco
    Ludwig, Heinz
    Vekemans, Marie Christiane
    Ketterer, Nicolas
    Daguenel, Anne
    Gorin, Norbert C.
    Harousseau, Jean Luc
    de Witte, Theo
    Morris, Curly
    Gahrton, Gosta
    [J]. BLOOD, 2010, 116 (21) : 1254 - 1254
  • [4] A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD
    Cavo, Michele
    Tacchetti, Paola
    Patriarca, Francesca
    Petrucci, Maria Teresa
    Pantani, Lucia
    Galli, Monica
    Di Raimondo, Francesco
    Crippa, Claudia
    Bringhen, Sara
    Offidani, Massimo
    Narni, Franco
    Montefusco, Vittorio
    Zamagni, Elena
    Spadano, Tonino
    Pescosta, Norbert
    Baldini, Luca
    Cellini, Claudia
    Caravita, Tommaso
    Ledda, Antonio
    Falcone, Antonietta
    Tosi, Patrizia
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Agostini, Paola
    Fiacchini, Mauro
    Baccarani, Michele
    [J]. BLOOD, 2009, 114 (22) : 148 - 149
  • [5] BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE AS PRIMARY INDUCTION THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA SIGNIFICANTLY DECREASES BONE RESORPTION WHILE SPARING BONE FORMATION AS COMPARED TO THALIDOMIDE-DEXAMETHASONE
    Tosi, P.
    Zamagni, E.
    Tacchetti, P.
    Perrone, G.
    Ceccolini, M.
    Brioli, A.
    Pallotti, M.
    Pantani, L.
    Petrucci, A.
    Baccarani, M.
    Cavo, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 265 - 265
  • [6] Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)
    Tacchetti, Paola
    Terragna, Carolina
    Catania, Gioacchino
    Marcatti, Magda
    Nozza, Andrea
    Ferrara, Felicetto
    Nobile, Francesco
    Califano, Catello
    Baraldi, Anna
    Gallamini, Andrea
    Musto, Pellegrino
    Tosi, Patrizia
    Galieni, Piero
    Pezzi, Annalisa
    Lanza, Francesco
    Ceccolini, Michela
    Ballerini, Filippo
    Catalano, Lucio
    Cangialosi, Clotilde
    Lazzaro, Antonio
    Paladini, Giorgio
    Mozzana, Ruggero
    Zannetti, Beatrice Anna
    Pinotti, Graziella
    Elice, Francesca
    Baccarani, Michele
    Boccadoro, Mario
    Cavaletti, Guido
    Cavo, Michele
    [J]. BLOOD, 2011, 118 (21) : 794 - 795
  • [7] BORTEZOMIB PLUS DEXAMETHASONE VERSUS REDUCED-DOSE BORTEZOMIB PLUS THALIDOMIDE-DEXAMETHASONE AS INDUCTION PRIOR TO AUTOLOGOUS TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA
    Harousseau, J. L.
    Avet-Loiseau, H.
    Mary, J.
    Facon, T.
    Attal, M.
    Doyen, C.
    Hulin, C.
    Garderet, L.
    Tiab, M.
    Lepeu, G.
    Araujo, C.
    Caillot, D.
    Petillon, M.
    Mathiot, C.
    Moreau, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 451 - 451
  • [8] EFFECT OF THALIDOMIDE-DEXAMETHASONE THERAPY ON BONE MARROW ANGIOGENESIS IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Ladeb, S.
    Mrad, K.
    Abdelkefi, A.
    Torjemane, L.
    Safra, I.
    Hdiji, S.
    Ben Romdhane, N.
    Mdhaffer, M.
    El Omri, H.
    Ben Othman, T.
    Ben Romdhane, K.
    Ben Abdeladhim, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512
  • [9] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    [J]. BLOOD, 2009, 114 (22) : 1494 - 1495
  • [10] Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
    Cavo, Michele
    Pantani, Lucia
    Petrucci, Maria Teresa
    Patriarca, Francesca
    Zamagni, Elena
    Donnarumma, Daniela
    Crippa, Claudia
    Boccadoro, Mario
    Perrone, Giulia
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Furlan, Anna
    Brioli, Annamaria
    Derudas, Daniele
    Ballanti, Stelvio
    Dessanti, Maria Laura
    De Stefano, Valerio
    Carella, Angelo Michele
    Marcatti, Magda
    Nozza, Andrea
    Ferrara, Felicetto
    Callea, Vincenzo
    Califano, Catello
    Pezzi, Annalisa
    Baraldi, Anna
    Grasso, Mariella
    Musto, Pellegrino
    Palumbo, Antonio
    [J]. BLOOD, 2012, 120 (01) : 9 - 19
12345